Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03864484
Other study ID # H30-038
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 7, 2019
Est. completion date March 30, 2022

Study information

Verified date August 2020
Source Kibi International University
Contact Hiroyuki Uchida
Phone +81-86-427-1111
Email hiroyukiuchida02@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

We plan to conduct a randomized controlled trial to examine whether usual rehabilitation plus an iPad application-based intervention improves post-stroke depression symptoms compared to usual rehabilitation alone.

The purpose of this pilot randomized controlled trial is to investigate the feasibility of the final randomized controlled trial.


Recruitment information / eligibility

Status Recruiting
Enrollment 32
Est. completion date March 30, 2022
Est. primary completion date March 30, 2022
Accepts healthy volunteers No
Gender All
Age group 40 Years and older
Eligibility Inclusion Criteria:

- 40 years and older

- Males and females

- Center for Epidemiologic Studies Depression Scale score =16

- Mini Mental State Examination score = 24

- First stroke

- Native language is Japanese

- Written informed consent prior to participation

Exclusion Criteria:

- Major depressive disorder before onset of stroke

- Bilateral hemiplegia

- Vision or hearing deficits that negatively impact everyday life

- Severe aphasia

- Severe unilateral spatial neglect

- Diagnosis of neurodegenerative disease such as Parkinson's disease or multiple system atrophy

- Current life-threatening severe organ failure, musculoskeletal disorders, or cancer

Study Design


Intervention

Device:
iPad Application + Usual Rehabilitation
The experimental group receives usual rehabilitation. In addition, the experimental group will watch movies using the iPad application for 3 minutes, once daily for 5 weeks.
Behavioral:
Usual rehabilitation
The control group receives usual rehabilitation.

Locations

Country Name City State
Japan Kurashiki Heisei Hospital Kurashiki Okayama

Sponsors (1)

Lead Sponsor Collaborator
Kibi International University

Country where clinical trial is conducted

Japan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Depression severity as measured by the Center for Epidemiologic Studies Depression Scale (CES-D) score. Change from Baseline CES-D at 5 weeks
Secondary Health-related quality of life as measured by the 36-item short-form Medical Outcome Study Questionnaire (SF-36). Change from Baseline SF-36 at 5 weeks
Secondary Activities of daily living as measured by Functional Independence Measure (FIM). Change from Baseline FIM at 5 weeks
Secondary Dynamic standing balance as measured by Functional Reach Test (FRT). Change from Baseline FRT at 5 weeks
Secondary Safety is defined as the proportion of patients who experience an intervention-related adverse event or any adverse event during the study. Adverse events, whether or not considered causally related to the study intervention, include death and life-threatening illness or injury requiring prolonged hospitalization or resulting in persistent disability. The period from the start of the intervention to 5 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05612659 - Developing an EEG Probe for Studying and Modulating Cognitive Control N/A
Active, not recruiting NCT06451965 - SCED - Wisdom Enhancement for Post-Stroke Depression N/A
Completed NCT04093843 - TMS for Post Stroke Depression N/A
Recruiting NCT05516680 - Effects and Central Mechanism of Electroacupuncture and MRI-navigated rTMS for PSD N/A
Recruiting NCT04876066 - Use of Transmucosal Ketamine in Post Stroke Depression Phase 1
Recruiting NCT03159351 - The Antidepressant Effects of rTMS After Ischemic Stroke N/A
Recruiting NCT05310175 - Efficacy of Acupuncture at Acupoints Group Around the Base of Skull for Post-Stroke Depression N/A
Completed NCT03639259 - Emotional and Cognitive Determinants of Post-stroke Fatigue
Completed NCT02472613 - Acupuncture for Ischemic Post-stroke Depression N/A
Completed NCT04008719 - ATtention Test and Executive Functions After STroke to Predict Depression. N/A
Recruiting NCT05241782 - The Effect of Auricular Acupressure on the Improvement of Anxiousness, Depression and Heart Rate Variability in Stroke Patients N/A
Withdrawn NCT03761303 - rTMS as an add-on Therapy in Patients With Post-stroke Depression N/A
Completed NCT04318951 - Impact of Intensive Social Interaction on Post-Stroke Depression in Individuals With Aphasia N/A
Completed NCT04560413 - Depression, Anxiety and SARS-CoV-2 (Covid-19) Phobia in Post-stroke Patients
Recruiting NCT05187975 - Integrated Rehabilitation in Treating Post-stroke Depression N/A
Completed NCT06157333 - Efficacy of Accelerated Repetitive Transcranial Magnetic Stimulation on Patients With Post-stroke Depression N/A
Completed NCT03829397 - To Investigate the Correlation of Stroke Patients and Demoralized
Recruiting NCT03256305 - A Study of rTMS Personalized Precision Treatment of Post-stroke Depression N/A
Recruiting NCT03789994 - Affective Touching on Poststroke Depression N/A
Completed NCT05932550 - Safety of Maraviroc for Post-stroke Depression Phase 2